Research Topics
| A SeigneurinSummaryAffiliation: CHU de Grenoble Country: France Publications
| Collaborators
|
Detail Information
Publications
Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001L E Joergensen
Danish Breast Cancer Cooperative Group, Section 2501, Blegdamsvej 9, DK 2100 Kbh Ø, Denmark
Breast 17:587-91. 2008..The prognostic influence of multifocality in breast cancer patients. Breast 2004;13:188-193]...
Artefact-free trends in breast cancer incidence over two decades in a whole French DépartementArnaud Seigneurin
Hospices Civils de Lyon, Service de Biostatistiques, Lyon F 69424, France
Breast 17:580-6. 2008..At most, the increase due to screening would reach 50%. In women aged 70-84, no real incidence increase was suspected if we assume that changes in clinical practices and screening led to more breast cancer cases collected...
Comparison of interval breast cancer rates for two-versus single-view screening mammography: a population-based studyA Seigneurin
Registre du Cancer de l Isère, 23 Chemin des Sources, Meylan, France
Breast 18:284-8. 2009..To determine whether the implementation of two-view mammography was followed by a reduction in the rates of interval cancers...
Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive casesArnaud Seigneurin
Registre du Cancer de l Isère, Centre Hospitalier Universitaire de Grenoble, BP 217, Pavillon E, 38043 Grenoble Cedex 9, France
Breast Cancer Res Treat 127:221-8. 2011....
Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry dataArnaud Seigneurin
Registre du Cancer de l Isère, Centre Hospitalier Universitaire de Grenoble, BP 217, Pavillon E, 38043 Grenoble Cedex 9, France
BMJ 343:d7017. 2011....
Analysis of the effect of age on the prognosis of breast cancerC Cluze
Cancer Registry of Isère, Meylan, France
Breast Cancer Res Treat 117:121-9. 2009..Our findings suggest that when taking into account grade and stage, the time-varying impact of young age at diagnosis is limited to grade 3 tumors, without evidence of worst prognosis at 5 years for the youngest women...
